CA IX—NIR dyes and their uses
Inventors
Kularatne, Sumith A • Gagare, Pravin • KANDULURU, Ananda Kumar
Assignees
Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Abstract
The present disclosure relates to compounds that are useful as near-infrared fluorescence probes, wherein the compounds include i) a ligand that binds to the active site of carbonic anhydrase, ii) a dye molecule, and iii) a linker molecule that comprises an amino acid, amide, ureido, or polyethylene glycol derivative thereof. The disclosure further describes methods and compositions for making and using the compounds, methods incorporating the compounds, and kits incorporating the compounds.
Core Innovation
The invention relates to CA IX-targeted near-infrared (NIR) fluorescent probe conjugates and kits. A first compound is provided according to the structure B—W—X—Y—Z, where B is a CA IX-targeted molecule, W is an extended hydrophobic residue, X is a hydrophobic spacer, Y is an amino acid spacer, and Z is a NIR dye.
The kit further comprises a second compound that comprises a pteroyl ligand conjugated to an amino acid linking group or a PSMA-targeting compound conjugated to an amino acid linking group. The disclosed conjugate design pairs an amino-acid-based linking group with a NIR dye component Z and a CA IX-targeted molecule component, and includes pteroyl ligand or PSMA-targeting component conjugated to an amino acid linking group.
The specification describes targeting CA IX in the context of hypoxia and tumor marker targeting, including hypoxia-related tissue targeting. It also describes optical imaging with NIR excitation light, absorption/emission wavelength ranges, and image-guided surgery.
Claims Coverage
The independent claim is a kit claim that includes two compound types with a shared amino acid linking/conjugation concept. The independent claim contains inventive features defining a CA IX-targeted NIR dye conjugate structure B—W—X—Y—Z and a pteroyl- or PSMA-targeting conjugate to an amino acid linking group included in the kit. Dependent claims refine the kit by specifying inclusion of both conjugate types and by narrowing the NIR dye options for Z to named dyes, with further narrowing to S0456.
Kit with CA IX-targeted B—W—X—Y—Z NIR dye first compound
A kit comprising a first compound having the formula B—W—X—Y—Z wherein B is a CA IX-targeted molecule, W is an extended hydrophobic residue, X is a hydrophobic spacer, Y is an amino acid spacer, and Z is a NIR dye.
Second compound includes pteroyl or PSMA conjugated to an amino acid linking group
A kit comprising a second compound wherein the second compound comprises a pteroyl ligand conjugated to an amino acid linking group or a PSMA-targeting compound conjugated to an amino acid linking group.
Kit includes both pteroyl-ligand and PSMA-targeting conjugates to the same amino acid linking group
The kit wherein the second compound comprises a pteroyl ligand conjugated to an amino acid linking group and a PSMA-targeting compound conjugated to the amino acid linking group.
Named NIR dye selection for Z with structural substituent constraints
The kit wherein Z is selected from LS288, IR800, SP054, S0121, S2076, and S0456 and the structure includes substituents R41, R42, R43, R44, R45, R46, R47, and R48 where H or SO3H can occur and X can be O, S, or N.
S0456 as the selected NIR dye Z
The kit wherein Z is S0456.
Overall, claim coverage centers on a kit that combines a CA IX-targeted NIR dye conjugate defined by the B—W—X—Y—Z framework with an additional conjugate comprising either a pteroyl ligand or a PSMA-targeting compound conjugated to an amino acid linking group. Dependent claims narrow the kit composition to include both pteroyl and PSMA conjugates and further restrict the NIR dye options for Z, including a specific selection of S0456.
Stated Advantages
Improved tumor-to-background.
Deeper tissue visualization.
Fast clearance.
Documented Applications
Optical imaging associated with NIR fluorescence upon excitation, including near-infrared excitation ranges and absorption/emission wavelength ranges.
Diagnostic and optical imaging using excitation light in the NIR range with CA IX targeting.
Image-guided surgery.
Disease diagnosis.
Interested in licensing this patent?